NCT07702097Not yet recruiting
Effect of Ajwa Seed Powder on HbA1c and Body Composition in Overweight and Obese Patients With Type 2 Diabetes Mellitus
Effect of Ajwa Seed Powder on HbA1c and Body Composition in Overweight and Obese Patients With Type 2 Diabetes Mellitus: A Single-Arm Interventional Stuy
Source: ClinicalTrials.gov · Last updated 14 Jul 2026
Brief summary (registry, in English)
The goal of this interventional study (clinical trial) is to check if ajwa seed powder can treat type 2 diabetes mellitus in overweight and and obese patients with type 2 diabetes mellitus including both male and female of the age group between 30-50. The main question is what would be the impact of ajwa seed powder on HbA1c and body composition in overweight and obese patients with type 2 diabetes mellitus which aim to result in better glycemic control particular Hba1c, and body composition improvement in type 2 diabetes mellitus patients Participants will be asked to consume 4 grams of ajwa seed powder per day
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 6 May 2026
- Start date
- Jun 2026
- Primary completion date
- Jun 2027
- Lead sponsor
- University of Veterinary and Animal Sciences, Lahore - Pakistan
- Diseases
- Obesity, Type 2 diabetes
- NCT number
- NCT07702097
What you commit to
- Study type: Interventional
- Planned participants: 30
- From Jun 2026 to the primary completion date, Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Age: 30-50 years
- Gender: Male/female
- Body Mass Index (BMI): 25-35 kg/m²
- Type 2 diabetes mellitus: HbA1c ≥ 6.5% Exclusion criteria History of alcoholic liver disease or cirrhosis; liver dysfunction based on initial blood tests
- Patients being treated with insulin
- High initial levels of serum creatinine (men\>1.5 mg/dl; women\>1.2 mg/dl)
- Pregnant/lactating females or women who cannot take proper contraceptive measures
- Symptoms consistent with peptic ulcer disease or history of peptic ulcers
- Active cancer patients
- Severe non-diabetes-related illnesses
- Patients with heart, liver, or lung failures
- Patients with blood disorders or on anticoagulant drugs such as warfarin Any other disease as decided by the principal investigator, which might put the safety of the subjects at risk while conducting the test
Age in the registry: 30 years to 50 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sultan Hospital Coordinator of this site? Confirm its status | Sheikhupura | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.